N,N-Dimethylglycine → 2-Dimethylamino-N-{4-[2-oxo-3-(4-phenoxyphenyl)-2,3-dihydroimidazol-1-yl]phenyl}acetamide

HRID 723374

Reaktionsgleichung

Reaktionsgleichung von HRID 723374
[B-](F)(F)(F)F.CCOC(C(C#N)=NOC(N(C)C)=[N+](C)C)=O.[NH2:23][C:24]1[CH:29]=[CH:28][C:27]([N:30]2[CH:34]=[CH:33][N:32]([C:35]3[CH:40]=[CH:39][C:38]([O:41][C:42]4[CH:47]=[CH:46][CH:45]=[CH:44][CH:43]=4)=[CH:37][CH:36]=3)[C:31]2=[O:48])=[CH:26][CH:25]=1.CCN(C(C)C)C(C)C.[CH3:58][N:59]([CH3:64])[CH2:60][C:61](O)=[O:62]>CN(C=O)C.O>[CH3:58][N:59]([CH3:64])[CH2:60][C:61]([NH:23][C:24]1[CH:25]=[CH:26][C:27]([N:30]2[CH:34]=[CH:33][N:32]([C:35]3[CH:40]=[CH:39][C:38]([O:41][C:42]4[CH:47]=[CH:46][CH:45]=[CH:44][CH:43]=4)=[CH:37][CH:36]=3)[C:31]2=[O:48])=[CH:28][CH:29]=1)=[O:62]

Komponenten

7

Versuchsvorschrift

TOTU (327 mg) was added to a solution of 1-(4-aminophenyl)-3-(4-phenoxyphenyl)-1,3-dihydroimidazol-2-one (343 mg) in DMF (3 ml) at 0° C. After 10 minutes, Hünig base (130 mg) and then a solution of dimethylglycine (103 mg) in DMF (1 ml) was added. After a reaction time of 12 hours at room temperature, the mixture was mixed with water and extracted with ethyl acetate. The organic phase was washed with sodium bicarbonate solution, dried over magnesium sulfate and concentrated. The residue was purified by preparative HPLC. The product with the molecular weight of 428.50 (C25H24N4O3); MS (ESI): 429 ([M+H]+) was obtained as hydrotrifluoroacetate in this way.

Aufarbeitung

  1. extractionextracted with ethyl acetate
  2. washThe organic phase was washed with sodium bicarbonate solution
  3. dry with materialdried over magnesium sulfate
  4. concentrationconcentrated
  5. customThe residue was purified by preparative HPLC
  6. customMS (ESI): 429 ([M+H]+) was obtained as hydrotrifluoroacetate in this way

Quellen und Nachweise

ORD-Eintrag
ord-2ec5c750372743508bfd8f7ef27ffb95
Quelldatensatz
uspto-grants-2006_11
Patentnummer
US07141561B2

Verknüpfte Notizen

Wird geladen…